Verrica Pharmaceuticals Inc. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/347b291f-9da3-4d39-b59a-eb84388beb43/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-12.2M | 2025-01-01 – 2025-12-31 | evidence 0001660334-26-000008 |
| FY 2024 | $-65.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-037172 |
| FY 2023 | $-65.8M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-022659 |
| FY 2022 | $-21.3M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006118 |
| FY 2021 | $-30.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002685 |
| FY 2020 | $-40.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013876 |
| FY 2019 | $-30.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010832 |
| FY 2018 | $-21.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006800 |
| FY 2017 | $-4.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006800 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Verrica Pharmaceuticals Inc. — all facts · Revenue · Net Income